These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15451427)

  • 21. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions.
    Tuominen A; Miller YI; Hansen LF; Kesäniemi YA; Witztum JL; Hörkkö S
    Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2096-102. PubMed ID: 16794225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
    Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
    J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J
    Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immuno-morphologic detection of specific APO-B antigenic determinants in normal intima and atherosclerotic plaques in the human aorta].
    Shekhonin BV; Tararak EM; Kovaleva EA; Ianushevskaia EV; Trakht IN
    Arkh Patol; 1989; 51(2):23-30. PubMed ID: 2469412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
    Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
    Torzewski M; Shaw PX; Han KR; Shortal B; Lackner KJ; Witztum JL; Palinski W; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2307-12. PubMed ID: 15528482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein.
    Valentinova NV; Gu ZW; Yang M; Yanushevskaya EV; Antonov IV; Guyton JR; Smith CV; Gotto AM; Yang CY
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
    Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The first human monoclonal antibody to oxidized LDL.
    Getz GS
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1254-5. PubMed ID: 11498447
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.
    Fredrikson GN; Hedblad B; Berglund G; Alm R; Ares M; Cercek B; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):872-8. PubMed ID: 12649091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction: effects of LDL oxidation.
    Negri S; Roma P; Fogliatto R; Uboldi P; Marcovina S; Catapano AL
    Atherosclerosis; 1993 Jun; 101(1):37-41. PubMed ID: 7692863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody.
    Nicolo D; Goldman BI; Monestier M
    Arthritis Rheum; 2003 Oct; 48(10):2974-8. PubMed ID: 14558104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of modified tryptophan residues in apolipoprotein B-100 derived from copper ion-oxidized low-density lipoprotein.
    Yang C; Gu ZW; Yang M; Lin SN; Siuzdak G; Smith CV
    Biochemistry; 1999 Nov; 38(48):15903-8. PubMed ID: 10625456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional specificities of monoclonal anti-human apolipoprotein B antibodies.
    Krul ES; Kleinman Y; Kinoshita M; Pfleger B; Oida K; Law A; Scott J; Pease R; Schonfeld G
    J Lipid Res; 1988 Jul; 29(7):937-47. PubMed ID: 2457642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
    Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
    Fredrikson GN; Andersson L; Söderberg I; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Autoimmunity; 2005 Mar; 38(2):171-9. PubMed ID: 16040338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen.
    Furuhata A; Honda K; Shibata T; Chikazawa M; Kawai Y; Shibata N; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1393-401. PubMed ID: 22716076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction.
    Kayo S; Ohsawa M; Ehara S; Naruko T; Ikura Y; Hai E; Yoshimi N; Shirai N; Tsukamoto Y; Itabe H; Higuchi K; Arakawa T; Ueda M
    Am Heart J; 2004 Nov; 148(5):818-25. PubMed ID: 15523312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.